Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year-old Alyssa was in remission, and she continues to do well several months later.

Gene Therapy as an Emerging Therapeutic Approach to Breast Cancer: New Developments and Challenges

HOPA Bulletin

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Alexa Miller on LinkedIn: I want to thank Anschutz Medical College and Scientific Solutions for…

News Archives - Page 1238 of 10145 - KYMA

News Archives - Page 1238 of 10145 - KYMA

FDA considers gene therapy for sickle cell disease: Cure at a cost.

Prime Editing Oversimplified. It has been 8 years since the first…, by Anush Mutyala

Pfizer tags early research programs for 'externalization' as it narrows focus in rare disease, cancer : r/biotechnologynews

Spencer Waspi on LinkedIn: Russia/Ukraine Energy Implications

New Gene Editing Tool Helps Zero in on Small Cancer-Linked Mutations, Newsroom

HOPA Bulletin

Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases